- Residual enzyme monitoring in glycoprotein synthesis and modification processes - Process-related impurity testing in glycoengineered biopharmaceutical manufacturing - Quality control of enzyme-treated biological intermediates and final products - Support for glycoengineering process development and optimization
Product Overview :
This kit employs a double-antibody sandwich ELISA format for the quantitative determination of β-1,4-N-acetylgalactosaminyltransferase residues in biological samples. It is suitable for process impurity testing during glycoprotein and glycoengineered product development.
Features & Benefits :
- Sandwich immunoassay format delivers high specificity and minimizes cross-reactivity - Quantitative results with traceability to calibration standards - Validated performance across common buffer and formulation matrices - Streamlined protocol fits standard ELISA workflows